InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Schwartz Jeffrey Lawrence, 董事. Officer active across 4 companies, notably SpringWorks Therapeutics, Inc.. In total, 8 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €47.2m. Activity tracked since 20 May 2021. The latest transaction was filed on 8 September 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Schwartz Jeffrey Lawrence
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
3,890 股@ US$25.178Common SharesSEC:0000950130-26-000223:0
7,217 股Common SharesSEC:0000950130-26-000223:1
10,909 股Common SharesSEC:0000950170-25-113627:0
14,300 股0Class A Common StockSEC:0000950170-24-065323:0
4,648 股0Common StockSEC:0000899243-23-013903:0
1,750,000 股@ US$28.50100.0% 占其流量Common StockSEC:0000899243-23-009117:0
4,818 股0Common StockSEC:0000899243-22-019105:0
1,106 股0Common StockSEC:0000899243-21-020446:0
8 条申报中的 8 条
About Schwartz Jeffrey Lawrence
Schwartz Jeffrey Lawrence is Administrateur and a declarant connected to SpringWorks Therapeutics, Inc., KESTRA MEDICAL TECHNOLOGIES, LTD. and Rapid Micro Biosystems, INC. He has 6 filings in total, and across the 6 sampled filings the period runs from 2021-05-24 to 2025-09-08, with sell volume of EUR 47125891 and buy volume of EUR 0; the most common transaction nature is Attribution.
